Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial
Zobair M. Younossi, Maria Stepanova, Michael Charlton, Michael P. Curry, Jacqueline G. O'Leary, Robert S. Brown, Sharon Hunt
Dive into the research topics of 'Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial'. Together they form a unique fingerprint.